Le Lézard
Classified in: Health
Subject: PDT

Frontier - A Magazine about Alligator Bioscience and Immuno-oncology


STOCKHOLM, Dec 10, 2018 /PRNewswire/ -- The science behind the Nobel Prizes in Medicine and Chemistry is the core in Alligator's research and development

Read the full magazine through the link below.

About Alligator Bioscience

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator's growing pipeline includes five lead clinical and pre-clinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017, ALG.APV-527 and ATOR-1144). ADC-1013 (JNJ-7107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator's shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com.

CONTACT:

Peter Benson

Chairman of the Board of Directors

+46-706-691-100
+45-40-80-48-69
http://www.alligatorbioscience.com
[email protected]


Cecilia Hofvander

Director IR & Communications

+46-46-286-42-80
http://www.alligatorbioscience.com
[email protected]

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/alligator-bioscience/r/frontier---a-magazine-about-alligator-bioscience-and-immuno-oncology,c2696727

The following files are available for download:

https://mb.cision.com/Main/12681/2696727/960645.pdf

Frontier - A Magazine about Alligator Bioscience and Immuno-oncology #2, 2018

http://news.cision.com/alligator-bioscience/i/frontier-nr-2-2018-eng-cover,c2544074

Frontier nr 2 2018 ENG cover

SOURCE Alligator Bioscience


These press releases may also interest you

at 13:22
Florida's Leading Podiatric Group Takes Giant Leap Into Texas
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...

at 13:05
Dr. J. Mark Tuthill Joins Gestalt Diagnostics' Strategic Advisory Board
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...

at 12:45
Sogolytics Study Examines Patient Experience Gaps in Telehealth Adoption
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Announces Acquisition of Tricord, Inc.
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, Innovative Treatment Provider for Severe Mental Illness, Announces Closing of Oversubscribed $15 Million Series A Funding Round
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios Secures FDA Breakthrough Device Designation for JuxtaFlow® RAD, Showcases Pioneering Data at Society of Cardiovascular Anesthesiologists Annual Meeting
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

More news about Health...


News published on and distributed by: